MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing and managing MYH7-related cardiomyopathies, offering personalized treatment, early diagnosis, and family planning insights.
Explore beta-sarcoglycan defects, their impact on muscular dystrophies, and how genetic testing aids in diagnosis, personalized treatment, and disease management.
Discover how genetic testing aids in diagnosing calpain defects, enabling early intervention, personalized treatments, and informed family planning options.
Uncover how genetic testing diagnoses delta-sarcoglycan defects, aiding in early intervention, treatment strategies, and family planning for muscular dystrophies.
Explore genetic testing for dysferlinopathies. Gain insights on diagnosis, treatment, family planning, and research opportunities to better manage these muscular disorders.
Unlock insights into Duchenne Muscular Dystrophy with genetic testing. Discover early diagnosis, personalized treatment, and family planning strategies today.
Unlock the power of genetic testing to diagnose myotubularin defects, personalize treatment, and guide family planning for centronuclear myopathies effectively.
Discover how genetic testing identifies perlecan defects, aiding in early diagnosis, guiding treatments, predicting disease progression, and assisting in family planning.